Delta Lloyd’s Idexx Laboratories IDXX Stock Holding History

Delta Lloyd’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$2.19M	Buy	13,560 +2,618	+24%	+$425K	0.06%	271
2017 Q1	$1.69M	Hold	10,942	–	–	0.05%	288
2016 Q4	$1.28M	Buy	10,942 +5,211	+91%	+$595K	0.04%	319
2016 Q3	$646K	Hold	5,731	–	–	0.02%	510
2016 Q2	$532K	Buy	+5,731	New	+$492K	0.02%	551

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Delta Lloyd's IDXX Position: Q2 2017 in Review

Delta Lloyd increased its Idexx Laboratories (IDXX) stake by 24% in Q2 2017, buying an estimated $425K and bringing the position to 13,560 shares worth $2.19M. The position accounts for 0.06% of the portfolio, ranked #271.

Delta Lloyd first reported a position in IDXX in Q2 2016 and has held it in 5 quarters since. 582 funds tracked by Wall St. Rank hold IDXX as of Q2 2017.

Delta Lloyd held 13,560 shares of Idexx Laboratories worth $2.19M as of Q2 2017.
Delta Lloyd bought 2,618 Idexx Laboratories shares in Q2 2017, an estimated $425K.
Idexx Laboratories made up 0.06% of Delta Lloyd's portfolio in Q2 2017, its #271 holding.
Delta Lloyd first reported a position in Idexx Laboratories in Q2 2016 and has held it in 5 quarters since.
582 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.